Montlhery, France

Gérard Jung


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 133(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Gérard Jung: A Pioneer in Biologically Active Polypeptides**

Introduction

Gérard Jung, an innovative inventor based in Montlhery, France, has made significant contributions to the field of biotechnology. With a focus on biologically active polypeptides, his work aims to improve therapeutic applications and enhance medical treatments. His groundbreaking patent exemplifies his dedication to advancing medical science.

Latest Patents

Gérard Jung holds a patent titled "Fusion polypeptides of human serum albumin and a therapeutically active polypeptide." This patent encompasses biologically active polypeptides that consist of a therapeutically active polypeptide fused to human serum albumin or a variant. It details methods for preparing these fusion polypeptides, including nucleotide sequences that encode them, expression cassettes comprising these sequences, and self-replicating plasmids containing the expression cassettes. Furthermore, it describes pharmaceutical compositions that utilize these innovative fusion polypeptides to improve therapeutic efficacy.

Career Highlights

Throughout his career, Gérard Jung has been associated with Aventis Behring LLC, where he has played a vital role in research and development. His expertise in polypeptide fusion technology underscores his commitment to enhancing therapeutic options for patients. His innovative approach and dedication to his work have distinguished him within the biotechnology field.

Collaborations

Collaboration is key in innovative environments, and Gérard Jung has worked closely with esteemed colleagues such as Reinhard Fleer and Alain Fournier. Their combined efforts contribute to the advancement of biotechnology, focusing on developing novel therapeutic solutions that address critical health needs.

Conclusion

Gérard Jung's contributions to the field of biotechnology through his inventive work on fusion polypeptides demonstrate the vital role of innovation in enhancing medical treatments. His patent reflects his commitment to advancing therapeutic options, providing hope for improved health outcomes. As he continues to collaborate with skilled professionals, his impact on the industry will undoubtedly grow, paving the way for future advancements in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…